Soluble PD-L1 is associated with local and systemic inflammation markers in primary and secondary brain tumours

BACKGROUND: Immune-modulatory treatments have so far shown limited clinical activity in primary brain tumours. We aimed to investigate soluble programmed death receptor ligand 1 (sPD-L1) as systemic inflammation parameter in patients with brain tumour. METHODS: EDTA plasma was collected from 81 glio...

Descripción completa

Detalles Bibliográficos
Autores principales: Mair, Maximilian J, Pajenda, Sahra, Ilhan-Mutlu, Aysegül, Steindl, Ariane, Kiesel, Barbara, Widhalm, Georg, Dieckmann, Karin, Feldmann, Katharina, Hainfellner, Johannes, Marosi, Christine, Müllauer, Leonhard, Wagner, Ludwig, Preusser, Matthias, Berghoff, Anna S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662140/
https://www.ncbi.nlm.nih.gov/pubmed/33184096
http://dx.doi.org/10.1136/esmoopen-2020-000863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662140/
https://www.ncbi.nlm.nih.gov/pubmed/33184096
http://dx.doi.org/10.1136/esmoopen-2020-000863

Ejemplares similares